PharmaJet Presents Latest Research Showing Benefits of Needle-free at mRNA-Based Therapeutics Summit
Needle-free can increase immunogenicity, reduce costs, and improve patient experience GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will present their latest research results at the mRNA-Based Therapeutics Summit on July 27, 2022. The presentation, entitled Advances in mRNA … [Read more…]
